Bio-engineered Stent Market By Material Type (Medical-grade Stainless Steel, Cobalt-Chromium Alloy, Others), By Disease Indication (Coronary Heart Disease, Ischemic Heart Disease, Peripheral Artery Disease, Other), By End-User Segment (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027

"Bio-engineered stent market to exhibit dynamic growth during the forecast period" 

The global bio-engineered stent market is growing proficiently, expected to grow at a CAGR of 7.1%. Globally, growing prevalence of coronary heart diseases and other hearing related disorders will drive the market growth. Growing awareness about new medical technology along with the launch of advanced bio-engineered cardiac stents or coronary stents with integrated biological solutions and enhanced biomaterials are factors driving the overall growth of bio-engineered stent market on a global scale. 

Market Synopsis

Bioengineered Stent Market

Get a sample copy for more information

"Medical grade stainless steel segment expected to register higher growth by the end of 2027" 

Advancement in biodegradable metals for cardiovascular stents along with the development in the field of alloys will enhance the overall growth of the market. Metallic stents are usually used to endorse revascularization and preserve the patency of damaged arteries following angioplasty procedures. The intrinsic surface and mechanical properties of metals make them more attractive. For e.g. Genous Bio-engineered stent, it has an exceptional dual helix design that delivers natural conformability and has endothelial progenitor cell capture technology to defend counter to thrombus (blood clotting) and minimizes the recurrence of abnormal narrowing of an artery or valve by accelerating the natural restorative process. 

Bioengineered Stent Market

Get a sample copy for more information

"Coronary heart diseases to witness a significant CAGR"

Increasing hospital admissions for coronary heart-related disorders and its treatment generated maximum revenue share in 2018. Additionally, large patient pool with cardiovascular diseases and individuals for the early diagnosis of heart related conditions on a global scale will drive the market growth globally. In 2017, according to statistics by American College of Cardiology, cardiovascular disease accounted for more than 800,000 deaths in the United States. Additionally, increasing prevalence for acute coronary syndrome, ischemic heart disease, and peripheral artery disease will drive the demand for bio-engineered stent market. Advancement in bioengineering technology, FDA approval of new products, increasing geriatric population, and awareness, offers potential advantage as an elective treatment to high cost cardiac surgical procedures, and wide usage of top applications in the stent industry. 

Bioengineered Stent Market

Get a sample copy for more information

"Increasing geriatric population, FDA approval and the presence of top manufacturers holds North America in dominant position" 

In 2018, the U.S. produced maximum revenue in the bio-engineered stent market due to an increase in prevalence for cardiovascular disorders, increasing hospitals admissions for coronary heart disease treatment and launch of new products will boost the market growth. Presently, more than 92 million U.S. citizens are living with some form of cardiovascular condition or the after-effects of stroke. According to a 2016 study by American Heart Association, overall direct medical expenditure of cardiovascular diseases are projected to surge to around $749 billion in 2035 globally. Existence of numerous treatment options further upsurges patient compliance in safety and efficiency of treatment for cardiovascular-related disorders which in turn expected to drive the market growth. However, the higher expense of surgical procedures, less popularity among the physicians in the developed regions, complexity in R&D, and controlled returns may hamper the overall market growth on a global scale. 

Bioengineered Stent Market

"Increased research and development with strong product pipelines in the developed regions"

Major players in the bio-engineered stent market are ORBUSNEICH MEDICAL, Medtronic, plc., Abbott Laboratories, Vascular Concepts, C. R. Bard, Lombard Medical Technologies, Biotronik SE & Co. KG, Terumo Corporation, Endologix, Inc., Translumina GmbH and others. Major companies are emerging with advanced technologies with integrated biological solutions. Acquisitions, partnership agreements and enhanced R&D on medical technology will invent the development of bio-engineered stent market in the emerging nations in the near future. 

Bioengineered Stent Market

Historical & Forecast Period 

This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027

Report Scope by Segments

Market Segmentation 


Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million

 Material Type (2017–2027; US$ Mn)
 • Medical-grade Stainless Steel
 • Cobalt-Chromium Alloy
 • Others (Tantalum, Gold, Nitinol, Polymers)

 Disease Indication (2017–2027; US$ Mn)
 • Coronary Heart Disease
 • Ischemic Heart Disease
 • Peripheral Artery Disease
 • Other Cardiovascular Diseases

 End-User Segment (2017–2027; US$ Mn)
 • Hospitals
 • Specialty Clinics
 • Ambulatory Surgical Centers

 Geography Segment (2017–2027; US$ Mn)
 • North America (U.S., Rest of North America)
 • Europe (U.K., Germany, France, Rest of Europe)
 • Asia Pacific (Japan, China, India, Rest of Asia Pacific)
 • Rest of the World (Middle East & Africa, Latin America)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall bio-engineered stent market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report 

  • What are the current market trends and dynamics in the bio-engineered stent market and valuable opportunities for emerging players?
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which material type segment holds a larger market share and why?
  • Are low and middle-income economies investing in the bio-engineered stent market?
  • What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Published Date:  Aug 2019
Category:  Medical Devices
Report ID:   59855
Report Format:   PDF
Pages:   120
Rating:    4.1 (66)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support